Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,459 | 58 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Indivior Inc. | $330.05 | 13 | $0 (2024) |
| US WorldMeds, LLC | $314.16 | 11 | $0 (2019) |
| Collegium Pharmaceutical, Inc. | $133.20 | 4 | $0 (2018) |
| Daiichi Sankyo Inc. | $100.00 | 1 | $0 (2017) |
| JAZZ PHARMACEUTICALS INC. | $67.92 | 2 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $51.58 | 3 | $0 (2018) |
| SHIELD THERAPEUTICS INC | $50.74 | 3 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $48.98 | 3 | $0 (2018) |
| Alkermes, Inc. | $42.05 | 2 | $0 (2018) |
| ITF Therapeutics LLC | $40.77 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $346.82 | 15 | JAZZ PHARMACEUTICALS INC. ($67.92) |
| 2023 | $38.90 | 2 | Shield Therapeutics Inc ($20.01) |
| 2022 | $28.70 | 2 | Fidia Pharma USA Inc. ($15.25) |
| 2020 | $34.00 | 2 | Ipsen Biopharmaceuticals, Inc ($17.88) |
| 2019 | $465.90 | 14 | US WorldMeds, LLC ($236.32) |
| 2018 | $382.65 | 19 | Collegium Pharmaceutical, Inc. ($133.20) |
| 2017 | $161.83 | 4 | Daiichi Sankyo Inc. ($100.00) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Diabetes | ||||||
| 12/13/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Immunology | ||||||
| 12/03/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $24.07 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/29/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $16.00 | General |
| Category: Insulin Pump | ||||||
| 10/02/2024 | ITF Therapeutics LLC | — | Food and Beverage | In-kind items and services | $40.77 | General |
| 09/27/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Hematology | ||||||
| 09/26/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $19.96 | General |
| Category: Endocrinology | ||||||
| 08/06/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $33.96 | General |
| Category: NEUROLOGY | ||||||
| 08/06/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $33.96 | General |
| Category: NEUROLOGY | ||||||
| 08/02/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $27.19 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/02/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: NEUROLOGY | ||||||
| 06/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Diabetes | ||||||
| 06/14/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: OUD | ||||||
| 03/01/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Hematology | ||||||
| 10/27/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Hematology | ||||||
| 04/27/2023 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: OUD | ||||||
| 11/21/2022 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: OUD | ||||||
| 09/19/2022 | Fidia Pharma USA Inc. | HYMOVIS (Device), TRILURON | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: OSTEOARTHRITIS | ||||||
| 09/29/2020 | Ipsen Biopharmaceuticals, Inc | DYSPORT (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Neurology | ||||||
| 01/30/2020 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: OUD | ||||||
| 12/05/2019 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: OUD | ||||||
| 10/10/2019 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: OUD | ||||||
| 09/14/2019 | US WorldMeds, LLC | Lucemyra/Lofexidine (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: Psychiatry/Psychology | ||||||
| 08/23/2019 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: OUD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 168 | 336 | $40,122 | $20,311 |
| 2022 | 13 | 407 | 858 | $91,815 | $48,268 |
| 2021 | 11 | 273 | 663 | $62,361 | $32,691 |
| 2020 | 10 | 289 | 661 | $63,491 | $27,192 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 40 | 103 | $17,270 | $9,238 | 53.5% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 35 | 75 | $8,080 | $4,515 | 55.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 27 | 54 | $7,040 | $3,138 | 44.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $3,522 | $1,585 | 45.0% |
| 98926 | Osteopathic manipulative treatment, 3-4 body regions | Office | 2023 | 23 | 31 | $2,325 | $995.52 | 42.8% |
| Q3014 | Telehealth originating site facility fee | Office | 2023 | 14 | 29 | $1,160 | $569.12 | 49.1% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2023 | 14 | 29 | $725.00 | $270.75 | 37.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 60 | 154 | $23,483 | $14,109 | 60.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 54 | 139 | $16,172 | $8,214 | 50.8% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 47 | 131 | $14,410 | $7,972 | 55.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 19 | 24 | $4,730 | $3,065 | 64.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 19 | $4,940 | $2,900 | 58.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 19 | 19 | $5,636 | $2,748 | 48.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $5,329 | $2,449 | 46.0% |
| Q3014 | Telehealth originating site facility fee | Office | 2022 | 38 | 97 | $3,880 | $1,880 | 48.5% |
| 98926 | Osteopathic manipulative treatment, 3-4 body regions | Office | 2022 | 33 | 55 | $4,125 | $1,822 | 44.2% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 33 | 71 | $4,055 | $886.92 | 21.9% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2022 | 37 | 93 | $2,325 | $875.35 | 37.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 12 | 13 | $1,170 | $858.51 | 73.4% |
| 97110 | Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | Office | 2022 | 17 | 21 | $1,560 | $486.02 | 31.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 44 | 111 | $17,084 | $10,237 | 59.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 34 | 125 | $14,928 | $7,443 | 49.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 21 | 21 | $5,684 | $3,532 | 62.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 13 | 33 | $4,730 | $2,743 | 58.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 12 | 14 | $2,630 | $1,956 | 74.4% |
About Dr. Gary Wang, MD
Dr. Gary Wang, MD is a Physical Medicine & Rehabilitation healthcare provider based in Buffalo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053382051.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Wang, MD has received a total of $1,459 in payments from pharmaceutical and medical device companies, with $346.82 received in 2024. These payments were reported across 58 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,459).
As a Medicare-enrolled provider, Wang has provided services to 1,137 Medicare beneficiaries, totaling 2,518 services with total Medicare billing of $128,462. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Buffalo, NY
- Active Since 01/28/2006
- Last Updated 01/13/2023
- Taxonomy Code 208100000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053382051
Products in Payments
- SUBLOCADE (Drug) $330.05
- Lucemyra/Lofexidine (Drug) $314.16
- Morphabond ER (Drug) $100.00
- NucyntaER (Drug) $93.34
- EPIDIOLEX (Drug) $67.92
- OXTELLAR XR (Drug) $51.58
- ACCRUFER (Drug) $50.74
- Vivitrol 380 mg (Drug) $42.05
- Fabhalta (Drug) $33.21
- APTIOM (Drug) $30.64
- XTAMPZA (Drug) $29.66
- Levorphanol (Drug) $29.56
- VOQUEZNA (Drug) $27.19
- INSPIRE (Device) $25.74
- GELSYN 3 (Device) $24.61
- JORNAY PM (Drug) $24.07
- MOUNJARO (Drug) $20.01
- Tirosint (Drug) $19.96
- BROVANA (Drug) $18.34
- DYSPORT (Drug) $17.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Buffalo
Dr. Jonathan Hall, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $1,834
James Czyrny, Md, MD
Physical Medicine & Rehabilitation — Payments: $1,354
Dr. Cindy Romanowski, Md, MD
Physical Medicine & Rehabilitation — Payments: $548.99
Dr. David Brooks, Md, MD
Physical Medicine & Rehabilitation — Payments: $241.47
Nadeem Hussain, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $52.33
Jong-Chaur Shieh, Md, MD
Physical Medicine & Rehabilitation — Payments: $50.93